XML 64 R51.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details 2) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues      
Total net revenues $ 559,386 $ 882,011 $ 13,062,373
Parent [Member]      
Revenues      
Sale of medical equipment 342,344 882,011 13,062,373
Provision of OSAS diagnostic services 217,042
Total net revenues 559,386 882,011 13,062,373
Cost of revenue      
Sale of medical equipment (464,918) (1,655,970) (17,179,060)
Provision of OSAS diagnostic services (292,983)
Total cost of revenue (757,901) (1,655,970) (17,179,060)
Gross loss      
Sale of medical equipment (122,574) (773,959) (4,116,687)
Provision of OSAS diagnostic services (75,941)
Total gross loss (198,515) (773,959) (4,116,687)
Depreciation and amortization expense:      
Sale of medical equipment 535,800 1,328,403 1,232,263
Provision of OSAS diagnostic services 291,830
Total depreciation and amortization expenses 827,630 1,328,403 1,232,263
Capital expenditure      
Sale of medical equipment 16,137 40,780 636,130
Provision of OSAS diagnostic services 760,191
Total capital expenditure $ 776,328 $ 40,780 $ 636,130